Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug 4:5:265.
doi: 10.3389/fgene.2014.00265. eCollection 2014.

Genetic factors and manganese-induced neurotoxicity

Affiliations
Review

Genetic factors and manganese-induced neurotoxicity

Pan Chen et al. Front Genet. .

Abstract

Manganese (Mn), is a trace metal required for normal physiological processes in humans. Mn levels are tightly regulated, as high levels of Mn result in accumulation in the brain and cause a neurological disease known as manganism. Manganism shares many similarities with Parkinson's disease (PD), both at the physiological level and the cellular level. Exposure to high Mn-containing environments increases the risk of developing manganism. Mn is absorbed primarily through the intestine and then released in the blood. Excessive Mn is secreted in the bile and excreted in feces. Mn enters and exits cells through a number of non-specific importers localized on the cell membrane. Mutations in one of the Mn exporters, SLC30A10 (solute carrier family 30, member 10), result in Mn induced toxicity with liver impairments and neurological dysfunction. Four PD genes have been identified in connection to regulation of Mn toxicity, shedding new light on potential links between manganism and PD.

Keywords: Parkinson’s disease; manganese; manganism; neurotoxicity.

PubMed Disclaimer

References

    1. Andres-Mateos E., Perier C., Zhang L., Blanchard-Fillion B., Greco T. M., Thomas B., et al. (2007). DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc. Natl. Acad. Sci. U.S.A. 104 14807–14812 10.1073/pnas.0703219104 - DOI - PMC - PubMed
    1. Armstrong R. A. (2011). Visual symptoms in Parkinson’s disease. Parkinsons Dis. 2011:908306 10.4061/2011/908306 - DOI - PMC - PubMed
    1. Aschner M. (2000). Manganese: brain transport and emerging research needs. Environ. Health Perspect. 108(Suppl. 3), 429–432 10.1289/ehp.00108s3429 - DOI - PMC - PubMed
    1. Aschner M. (2002). Open issues from the 15th International Conference on Manganese. Neurotoxicology 23 123–125 10.1016/S0161-813X(01)00097-3 - DOI - PubMed
    1. Aschner M., Gannon M. (1994). Manganese (Mn) transport across the rat blood-brain barrier: saturable and transferrin-dependent transport mechanisms. Brain Res. Bull. 33 345–349 10.1016/0361-9230(94)90204-6 - DOI - PubMed

LinkOut - more resources